- Remove All
- Your shopping cart is currently empty
Icotrokinra is an orally bioavailable and highly selective antagonist of the interleukin-23 receptor (IL-23R), thereby interfering with IL-23-mediated signaling cascades. Icotrokinra inhibits IL-23-induced STAT3 phosphorylation in peripheral blood mononuclear cells with an IC50 value of 5.6 pM, and it suppresses IL-23-induced interferon-gamma production in natural killer cells with an IC50 value of 18.4 pM. Icotrokinra further demonstrates anti-inflammatory effects in a rat TNBS-induced colitis model, making it a compound of interest in the study of psoriasis, psoriatic arthritis, and inflammatory bowel disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $397 | In Stock | |
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Icotrokinra is an orally bioavailable and highly selective antagonist of the interleukin-23 receptor (IL-23R), thereby interfering with IL-23-mediated signaling cascades. Icotrokinra inhibits IL-23-induced STAT3 phosphorylation in peripheral blood mononuclear cells with an IC50 value of 5.6 pM, and it suppresses IL-23-induced interferon-gamma production in natural killer cells with an IC50 value of 18.4 pM. Icotrokinra further demonstrates anti-inflammatory effects in a rat TNBS-induced colitis model, making it a compound of interest in the study of psoriasis, psoriatic arthritis, and inflammatory bowel disease. |
Targets&IC50 | IL-23:7.1 pM (Kd) |
In vivo | In the TNBS-induced rat colitis model, oral administration of Icotrokinra at doses ≥0.3 mg/kg/day significantly reduced body weight loss and the colon weight/length ratio. In the IL-23-induced skin inflammation model, Icotrokinra at doses ≥10 mg/kg BID markedly suppressed IL-17A, IL-17F, and IL-22 gene expression and alleviated skin thickness.[1] |
Synonyms | PN-235, PN235, JNJ-77242113, JNJ77242113, JNJ-2113, JNJ2113 |
Molecular Weight | 1898.17 |
Formula | C90H120N20O22S2 |
Cas No. | 2763602-16-8 |
Smiles | N(C([C@H](CC1=CC2=C(C=C1)C=CC=C2)NC([C@H](CC3=CC=C(OCCN)C=C3)NC(=O)[C@H]4NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@H](CC=5C=6C(NC5)=C(C)C=CC6)NC(=O)[C@]([C@@H](C)O)(NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(C)=O)C(C)(C)SSC4(C)C)[H])=O)=O)C7(C(N[C@H](C(N[C@H](C(N[C@@H](CC=8C=CC=NC8)C(N(CC(N)=O)C)=O)=O)CC(N)=O)=O)CCC(O)=O)=O)CCOCC7 |
Color | White |
Appearance | Solid |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (42.15 mM), Sonication is recommended. H2O: ≥ 80 mg/mL, Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.